KAUST and Saudi healthtech company amplifAI health have signed an MoU to develop a new disease detection system. The system will combine amplifAI's AI technology with KAUST's HyplexTM hyperspectral imaging, initially for diabetic foot complications. Clinical trials are planned, with aims to reduce amputations and save Saudi Arabia over 2 billion Riyals annually. Why it matters: This partnership showcases the potential of combining Saudi AI and advanced imaging technologies to address pressing healthcare challenges in the region, particularly diabetes.
KAUST showcased its smart health technologies at the Global Health Exhibition in Riyadh, including AI-driven tools for autism diagnosis, SkinGPT-4 for dermatological image analysis, and nanobodies for detecting dengue and Zika viruses. They also presented a wirelessly connected smart bandage for monitoring wound parameters. KAUST signed agreements with Saudi partners for research collaborations during the event. Why it matters: KAUST's efforts in smart health innovation are poised to strengthen healthcare systems in Saudi Arabia and beyond, addressing critical medical challenges through advanced technologies.
Saudi health innovators are increasing investment in smart health solutions, using KAUST's infrastructure and expertise. The King Salman Center for Disability Research (KSCDR) and KCSH are partnering on AI-based methods to identify genetic causes of rare eye diseases. KAUST and the Saudi Food and Drug Administration (SFDA) are expanding their agreement to enhance cooperation on AI and digital innovation. Why it matters: These partnerships signal a concerted effort to leverage AI for addressing critical healthcare challenges and advancing the Kingdom's health priorities.
KAUST has launched the Center of Excellence for Smart Health (KCSH), chaired by Professor Imed Gallouzi and co-chaired by Professor Xin Gao. The center aims to develop smart-health technologies, integrating AI, machine learning, and other disciplines to address health challenges. KCSH will collaborate with partners across Saudi Arabia to focus on personalized diagnosis, treatment, and prevention of diseases. Why it matters: This initiative addresses the evolving healthcare needs of Saudi Arabia's aging population and high prevalence of genetic diseases, positioning the Kingdom as a leader in smart health solutions.
KAUST is collaborating with medical centers and Alfaisal University to integrate smart and digital tools into the Saudi healthcare system. A key objective is to improve understanding of disease mechanisms for better diagnosis, treatment, and prevention, aligning with KSA's Vision 2030. KAUST has partnered with Alfaisal University to establish the Kingdom’s first M.D./Ph.D. program. Why it matters: These partnerships aim to transition Saudi Arabia's healthcare system towards precision and personalized medicine by training practitioners in AI and smart technologies.